Boothbay Fund Management’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,686
| Closed | -$33K | – | 1968 |
|
|
2022
Q2 | $33K | Hold |
11,686
| – | – | ﹤0.01% | 1871 |
|
|
2022
Q1 | $95K | Hold |
11,686
| – | – | ﹤0.01% | 1725 |
|
|
2021
Q4 | $93K | Hold |
11,686
| – | – | ﹤0.01% | 1559 |
|
|
2021
Q3 | $139K | Sell |
11,686
-6,913
| -37% | -$82.2K | ﹤0.01% | 1474 |
|
|
2021
Q2 | $288K | Buy |
18,599
+2,404
| +15% | +$37.2K | 0.01% | 1155 |
|
|
2021
Q1 | $389K | Hold |
16,195
| – | – | 0.01% | 879 |
|
|
2020
Q4 | $478K | Sell |
16,195
-3,470
| -18% | -$102K | 0.02% | 635 |
|
|
2020
Q3 | $301K | Buy |
19,665
+5,747
| +41% | +$88K | 0.02% | 689 |
|
|
2020
Q2 | $348K | Hold |
13,918
| – | – | 0.02% | 559 |
|
|
2020
Q1 | $284K | Buy |
+13,918
| New | +$284K | 0.02% | 493 |
|